Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Head and Neck Cancer Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Cancer is defined as unregulated and aberrant cell development that culminates in the formation of a tumour. This tumour could be malignant or noncancerous. The term "head and neck cancer" refers to a variety of malignant tumours that form in or around the throat, larynx, nose, sinuses, and mouth. Furthermore, squamous cells, which line wet surfaces such as the inside of the head and neck, are the origin of head and neck malignancies (for example, the mouth, nose, and throat). Different types of cells in the salivary glands can become malignant. Tobacco use, heavy alcohol use, and human papillomavirus (HPV) infection all raise the risk of head and neck cancer.

According to the National Center for Biotechnology Information, head and neck cancer market is the world's sixth most frequent disease, with over 630,000 new cases identified each year and over 350,000 deaths. Symptoms include a change in voice or hoarseness, a lump or sore that does not heal, a persistent sore throat, and inexplicable and prolonged difficulty swallowing. Tobacco usage, especially smokeless tobacco, is linked to 75 percent of head and neck malignancies. HPV infection is linked to a higher risk of some malignancies of the head and neck.

 

Head and Neck Cancer Market
Head and Neck Cancer Market

Need for effective and targeted treatment is critical to increase the survival rates

Physicians face a significant problem in treating head and neck cancer since affectivity and therapy options differ from patient to patient and tumour site. Surgical treatments for head and neck cancers are limited due to the complexity of face tissues and functions, with surgery being the primary means of treatment. Functions including chewing, talking, and swallowing may be impacted after surgery. For the treatment of the disease, doctors use surgical surgery in conjunction with radiation therapy. In the last ten years, the survival rate of head and neck cancer has dropped from 80% to 50%, owing to existing treatment choices that mostly manage the symptoms. Recent advancements in sophisticated chemotherapy and radiotherapy have allowed some facial functions to be preserved. Targeted molecular therapy, such as gene therapy, monoclonal antibodies, and antibody drug conjugates, has opened up new growth opportunities for the head and neck cancer industry.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027